<?xml version="1.0" encoding="UTF-8"?>
<compound>
  <id type="integer">345855</id>
  <title nil="true"/>
  <common-name>(5z)-3-benzyl-5-[[3-(3-chloro-4-methoxyphenyl)-1-phenylpyrazol-4-yl]methylidene]-2-sulfanylidene-1,3-thiazolidin-4-one</common-name>
  <description>(5z)-3-benzyl-5-[[3-(3-chloro-4-methoxyphenyl)-1-phenylpyrazol-4-yl]methylidene]-2-sulfanylidene-1,3-thiazolidin-4-one is a chemical compound with the formula C27H20ClN3O2S2. With an average molecular weight of 518.10 g/mol, (5z)-3-benzyl-5-[[3-(3-chloro-4-methoxyphenyl)-1-phenylpyrazol-4-yl]methylidene]-2-sulfanylidene-1,3-thiazolidin-4-one is a heavy molecule.</description>
  <cas nil="true"/>
  <pubchem-id>5917525</pubchem-id>
  <chemical-formula>C27H20ClN3O2S2</chemical-formula>
  <weight>518.1</weight>
  <appearance nil="true"/>
  <melting-point nil="true"/>
  <boiling-point nil="true"/>
  <density nil="true"/>
  <solubility nil="true"/>
  <specific-gravity nil="true"/>
  <flash-point nil="true"/>
  <vapour-pressure nil="true"/>
  <route-of-exposure nil="true"/>
  <target nil="true"/>
  <mechanism-of-toxicity nil="true"/>
  <metabolism nil="true"/>
  <toxicity nil="true"/>
  <lethaldose nil="true"/>
  <carcinogenicity nil="true"/>
  <use-source nil="true"/>
  <min-risk-level nil="true"/>
  <health-effects nil="true"/>
  <symptoms nil="true"/>
  <treatment nil="true"/>
  <created-at type="dateTime">2026-08-31T08:52:12Z</created-at>
  <updated-at type="dateTime">2026-08-31T08:52:12Z</updated-at>
  <interacting-proteins nil="true"/>
  <wikipedia nil="true"/>
  <uniprot-id nil="true"/>
  <kegg-compound-id nil="true"/>
  <omim-id nil="true"/>
  <chebi-id nil="true"/>
  <biocyc-id nil="true"/>
  <ctd-id nil="true"/>
  <stitch-id nil="true"/>
  <drugbank-id nil="true"/>
  <pdb-id nil="true"/>
  <actor-id nil="true"/>
  <organism nil="true"/>
  <export type="boolean">true</export>
  <metabolizing-proteins nil="true"/>
  <transporting-proteins nil="true"/>
  <moldb-smiles>COC1=C(C=C(C=C1)C2=NN(C=C2C=C3C(=O)N(C(=S)S3)CC4=CC=CC=C4)C5=CC=CC=C5)Cl</moldb-smiles>
  <moldb-formula>C27H20ClN3O2S2</moldb-formula>
  <moldb-inchi>InChI=1S/C27H20ClN3O2S2/c1-33-23-13-12-19(14-22(23)28)25-20(17-31(29-25)21-10-6-3-7-11-21)15-24-26(32)30(27(34)35-24)16-18-8-4-2-5-9-18/h2-15,17H,16H2,1H3/b24-15-</moldb-inchi>
  <moldb-inchikey>DNWCVZNYNCJXEV-IWIPYMOSSA-N</moldb-inchikey>
  <moldb-average-mass type="decimal" nil="true"/>
  <moldb-mono-mass type="decimal">517.0685469</moldb-mono-mass>
  <origin nil="true"/>
  <state nil="true"/>
  <logp>6.7</logp>
  <hmdb-id nil="true"/>
  <chembl-id nil="true"/>
  <chemspider-id nil="true"/>
  <structure-image-file-name nil="true"/>
  <structure-image-content-type nil="true"/>
  <structure-image-file-size type="integer" nil="true"/>
  <structure-image-updated-at type="dateTime" nil="true"/>
  <biodb-id nil="true"/>
  <synthesis-reference nil="true"/>
  <structure-image-caption nil="true"/>
  <chemdb-id>CHEM341748</chemdb-id>
  <dsstox-id nil="true"/>
  <toxcast-id nil="true"/>
  <stoff-ident-origin nil="true"/>
  <stoff-ident-id nil="true"/>
  <susdat-id nil="true"/>
  <iupac>(5z)-3-benzyl-5-[[3-(3-chloro-4-methoxyphenyl)-1-phenylpyrazol-4-yl]methylidene]-2-sulfanylidene-1,3-thiazolidin-4-one</iupac>
  <moldb-polar-surface-area nil="true"/>
  <moldb-refractivity nil="true"/>
  <moldb-polarizability nil="true"/>
  <moldb-rotatable-bond-count nil="true"/>
  <moldb-acceptor-count nil="true"/>
  <moldb-donor-count nil="true"/>
  <moldb-pka-strongest-acidic nil="true"/>
  <moldb-pka-strongest-basic nil="true"/>
  <moldb-physiological-charge nil="true"/>
  <moldb-number-of-rings nil="true"/>
  <moldb-alogps-logp nil="true"/>
  <moldb-alogps-logs nil="true"/>
  <moldb-alogps-solubility nil="true"/>
  <kingdom>Organic compounds</kingdom>
  <superklass>Organoheterocyclic compounds</superklass>
  <klass>Azoles</klass>
  <subklass>Pyrazoles</subklass>
  <paper-count type="integer" nil="true"/>
  <sync-id>CED0296209</sync-id>
  <structure-inchikey>DNWCVZNYNCJXEV-UHFFFAOYSA-N</structure-inchikey>
  <structure-fingerprint>800240000000000000000000000000000100000000400000404000000020100000000002002004000000000000000000801000000000000000000000c000000800000000000000200000100003000000000000000000000000000000000000400001001100008000080001001080400000000000000000000041c0200000800002000000000000800000000100000000000000000000000000000000000000000000080000000000000020010000020200040000000080000000000000000001000000000000000010000000040000000220040000000000000040000004000040000000800000000000080020000000000200000008</structure-fingerprint>
  <structure-pattern-fingerprint>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</structure-pattern-fingerprint>
  <structure-pickle type="binary" encoding="base64">776t3gAAAAAQAAAAAwAAAAAAAAAjAAAAJwAAAIABBgBgAAAAAQMIACgAAAAD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</structure-pickle>
  <structure-indexed-at type="dateTime">2026-09-19T05:44:46Z</structure-indexed-at>
</compound>
